Syllabus
US Market Access and Drug Pricing Policy Certificate Program
36 lessons, about 12 hours. Online and self-paced.
US Access Foundations
Map the stakeholders, launch milestones, coverage pathways, and financial relationships that determine patient access.
- 1US Pharmaceutical Stakeholder Map
- 2FDA Approval and Launch Milestones
- 3Drug Coverage and Reimbursement Routes
- 4Gross-to-Net Revenue and Access
Government Pricing Operations
Calculate and distinguish government price metrics while documenting participation, reporting, rebate, and federal purchasing obligations.
- 5Government Price Benchmark Selection
- 6Medicaid Participation and Product Classification
- 7AMP Transaction Classification Workshop
- 8Best Price and Reporting Controls
- 9Medicaid Basic Rebate Calculations
- 10Medicaid Inflation and Utilization Reconciliation
- 11ASP Reporting and Part B Payment
- 12340B Ceiling Prices and Duplicate Discounts
- 13Federal Purchasing Price Obligations
Medicare Pricing Policy
Assess negotiation eligibility, model statutory price limits, and translate Medicare reforms into operational and financial decisions.
- 14IRA Programs and Implementation Cycles
- 15Negotiation Eligibility and Selection Screening
- 16Orphan Exclusions and Eligibility Clocks
- 17MFP Statutory Ceiling Scenarios
- 18Manufacturer Negotiation Evidence and Decisions
- 19MFP Availability and Reconciliation Workflows
- 20Part D Redesign and Affordability
- 21Medicare Inflation Rebate Exposure
- 22GLOBE Implementation Readiness
Payer Access and Evidence
Evaluate payer-specific access barriers and prepare evidence and channel recommendations that support coverage decisions.
- 23Commercial Payer and PBM Decisions
- 24Commercial Contract Access Tradeoffs
- 25Medicare Coverage and Formulary Decisions
- 26Medicaid Coverage and State Access
- 27Medical and Pharmacy Channel Strategy
- 28AMCP Dossier Evidence Package
- 29Payer Communications Review Workshop
Pricing and Launch Execution
Build a practical access plan that connects payer priorities, value evidence, pricing economics, and launch readiness.
- 30Payer Segmentation and Account Prioritization
- 31Pricing Research and Value Strategy
- 32Integrated Gross-to-Net Pricing Model
- 33US Payer Access Launch Plan
- 34Access Performance and Strategy Revision
Policy Governance and Capstone
Maintain a defensible policy-monitoring process and present an integrated product access recommendation.
- 35Policy Monitoring and Escalation Register
- 36Integrated Market Access Strategy Capstone




























